BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 30304666)

  • 1. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma.
    Ferreira RG; Cardoso MV; de Souza Furtado KM; Espíndola KMM; Amorim RP; Monteiro MC
    Transl Res; 2019 Feb; 204():51-71. PubMed ID: 30304666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism in actions of HBV with aflatoxin in cancer development.
    Jin J; Kouznetsova VL; Kesari S; Tsigelny IF
    Toxicology; 2023 Nov; 499():153652. PubMed ID: 37858775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Frequency of Aflatoxin Induced TP53 Gene Codon 249 Mutation in Hepatocellular Carcinoma from Egyptian Patients Living in the Nile Delta Region.
    Mosbeh A; Abdelmaguid W; Ezzat S; Kohla M; Sultan MM; Abdel-Rahman MH
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3165-3168. PubMed ID: 37774068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenic effects of aflatoxin B1 among wheat handlers.
    Saad-Hussein A; Taha MM; Beshir S; Shahy EM; Shaheen W; Elhamshary M
    Int J Occup Environ Health; 2014; 20(3):215-9. PubMed ID: 25000109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.
    Huang MN; Yu W; Teoh WW; Ardin M; Jusakul A; Ng AWT; Boot A; Abedi-Ardekani B; Villar S; Myint SS; Othman R; Poon SL; Heguy A; Olivier M; Hollstein M; Tan P; Teh BT; Sabapathy K; Zavadil J; Rozen SG
    Genome Res; 2017 Sep; 27(9):1475-1486. PubMed ID: 28739859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aflatoxin exposure in a population of HIV patients at risk of hepatocellular carcinoma North-Central, Nigeria.
    Davwar P; David P; Imoh L; Duguru M; Zawaya K; Tsok Y; Sagay A; Okeke E
    Afr Health Sci; 2023 Jun; 23(2):81-87. PubMed ID: 38223595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia.
    Khedr SM; Ghareeb DA; Fathy SA; Hamdy GM
    BMC Pharmacol Toxicol; 2023 Aug; 24(1):42. PubMed ID: 37559065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequencies and spectra of aflatoxin B
    Minko IG; Luzadder MM; Vartanian VL; Rice SPM; Nguyen MM; Sanchez-Contreras M; Van P; Kennedy SR; McCullough AK; Lloyd RS
    NAR Mol Med; 2024 Apr; 1(2):ugae006. PubMed ID: 38779538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin B
    Narkwa PW; Blackbourn DJ; Mutocheluh M
    Infect Agent Cancer; 2017; 12():17. PubMed ID: 28344639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Copper or Zinc Organometallics on Cytotoxicity, DNA Damage and Epigenetic Changes in the HC-04 Human Liver Cell Line.
    Desaulniers D; Zhou G; Stalker A; Cummings-Lorbetskie C
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage checkpoint response to aflatoxin B1.
    Engin AB; Engin A
    Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.
    McCullough AK; Lloyd RS
    DNA Repair (Amst); 2019 May; 77():76-86. PubMed ID: 30897375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Life Exposure to Aflatoxin B1 in Rats: Alterations in Lipids, Hormones, and DNA Methylation among the Offspring.
    Rotimi OA; Onuzulu CD; Dewald AL; Ehlinger J; Adelani IB; Olasehinde OE; Rotimi SO; Goodrich JM
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33445757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods.
    Rushing BR; Selim MI
    Food Chem Toxicol; 2019 Feb; 124():81-100. PubMed ID: 30468841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action.
    Benkerroum N
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31936320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose microcystin-LR antagonizes aflatoxin B1 induced hepatocarcinogenesis through decreasing cytochrome P450 1A2 expression and aflatoxin B1-DNA adduct generation.
    Wang L; He L; Zeng H; Fu W; Wang J; Tan Y; Zheng C; Qiu Z; Luo J; Lv C; Huang Y; Shu W
    Chemosphere; 2020 Jun; 248():126036. PubMed ID: 32045972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal profile, levels of aflatoxin M1, exposure, and the risk characterization of local cheese '
    Kortei NK; Gillette VS; Wiafe-Kwagyan M; Ansah LO; Kyei-Baffour V; Odamtten GT
    Toxicol Rep; 2024 Jun; 12():186-199. PubMed ID: 38313814
    [No Abstract]   [Full Text] [Related]  

  • 18. Co-Occurrence of Aflatoxin B
    Sdogati S; Pacini T; Bibi R; Caporali A; Verdini E; Orsini S; Ortenzi R; Pecorelli I
    Foods; 2024 Jan; 13(2):. PubMed ID: 38254614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
    Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
    Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma.
    Hong Y; Zhang Y; Zhao H; Chen H; Yu QQ; Cui H
    Front Cell Dev Biol; 2022; 10():1051306. PubMed ID: 36467404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.